Peter Attia· MD
so we use Neo ement therapy for larger tumors to shrink the tumor in the breast shrink the tumor burden in the lymph nodes and to individualize or tailor treatment on the backside based on how much response there is
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so we use Neo ement therapy for larger tumors to shrink the tumor in the breast shrink the tumor burden in the lymph nodes and to individualize or tailor treatment on the backside based on how much response there is
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
by giving the drug therapy first we usually can shrink the tumor either in the breast or particularly in the lymph nodes as well and so that means we can offer very good outcomes the same good outcomes but with less surgery so women who might have needed a mastectomy might now be able to have a lumpectomy if the tumor shrinks or women who might have been obliged to undergo a so-called axillary lymph node dissection where all the lymph noes in the armpit are removed that carries a greater risk of limited restrictive uh limited range of motion in the arm or lymphadema in the arm now might be a candidate for a sentinal node biopsy